A 70-year-old male immigrant from Asia is brought to the emergency room with complaints of palpitations and light-headedness for 1 hour. The patient was sitting in his chair watching television when he felt his heart racing and became dizzy. He was unable to stand up from his chair because of weakness and light-headedness. His past medical history is notable for mitral stenosis secondary to rheumatic fever as a child. On arrival to the emergency department, the patient's temperature is 99.7°F (37.6°C), blood pressure is 110/55 mmHg, pulse is 140/min, and respirations are 15/min. The patient appears comfortable but anxious. Electrocardiogram shows atrial fibrillation with rapid ventricular response. The patient is started on dofetilide. Which of the following would be expected in this patient’s cardiac action potential as a result of this drug?
Q402
A 57-year-old man calls his primary care physician to discuss the results of his annual laboratory exams. The results show that he has dramatically decreased levels of high-density lipoprotein (HDL) and mildly increased levels of low-density lipoprotein (LDL). The physician says that the HDL levels are of primary concern so he is started on the lipid level modifying drug that most effectively increases serum HDL levels. Which of the following is the most likely a side effect of this medication that the patient should be informed about?
Q403
A 53-year-old male presents to his primary care provider for tremor of his right hand. The patient reports that the shaking started a few months ago in his right hand but that he worries about developing it in his left hand as well. He reports that the shaking is worse when he is sitting still or watching television and improves as he goes about his daily activities. The patient has a past medical history of hypertension, hyperlipidemia, and diabetes mellitus, and his home medications are hydrochlorothiazide, lisinopril, and atorvastatin. He works as an accountant and drinks 1-2 beers per week. He has a 15-pack-year smoking history but quit ten years ago. On physical exam, the patient has bilateral hand tremors with a frequency of 4-5 Hz. The tremor improves on finger-to-nose testing. His upper extremities also display a mild resistance to passive movement, and he has 2+ reflexes throughout. He has no gait abnormalities, and he scores 29/30 on the Mini-Mental State Examination (MMSE).
This patient should be started on which of the following classes of medications?
Q404
A 52-year-old man with a history of hypertension and hyperlipidemia comes to the physician because of a 10-month history of substernal chest pain on exertion that is relieved with rest. His pulse is 82/min and blood pressure is 145/82 mm Hg. He is prescribed a drug that acts by forming free radical nitric oxide. The patient is most likely to experience which of the following adverse effects as a result of this drug?
Q405
A 68-year-old male with a history of congestive heart failure presents to his cardiologist complaining of mild dyspnea on exertion and swollen ankles. His past medical history is also significant for hypertension and alcohol abuse. He has a 50 pack-year smoking history. He currently takes lisinopril, aspirin, and metoprolol. His temperature is 99°F (37.2°C), blood pressure is 135/85 mmHg, pulse is 85/min, and respirations are 18/min. An echocardiogram reveals an ejection fraction of 35%. His cardiologist adds an additional medication to the patient’s regimen. Two weeks later, the patient notices yellow halos in his vision. Which of the following medications did this patient most likely start taking?
Q406
A previously healthy 36-year-old woman comes to the emergency department because of a progressively worsening headache for 5 days. She vomited twice after waking up this morning. She does not smoke or drink alcohol. She is sexually active with one male partner and uses an oral contraceptive. Her temperature is 37.5°C (99.5°F), pulse is 105/min, and blood pressure is 125/80 mm Hg. Examination shows tearing of the right eye. The pupils are equal and reactive to light; right lateral gaze is limited. Fundoscopic examination shows bilateral optic disc swelling. The remainder of the examination shows no abnormalities. An MR venography of the head shows a heterogeneous intensity in the left lateral sinus. Which of the following is the most appropriate next step in management?
Q407
A 48-year-old man presents to the emergency department with complaints of substernal chest pain for the past 1 hour. The pain is crushing in nature and radiates to his neck and left arm. He rates the pain as 7/10. He gives a history of similar episodes in the past that resolved with rest. He is a non-smoker and drinks alcohol occasionally. On physical examination, the temperature is 37.0°C (98.6°F), the pulse rate is 130/min and irregular, the blood pressure is 148/92 mm Hg, and the respiratory rate is 18/min. The physician immediately orders an electrocardiogram, the findings of which are consistent with an acute Q-wave myocardial infarction (MI). After appropriate emergency management, he is admitted to the medical floor. He develops atrial fibrillation on the second day of admission. He is given a β-adrenergic blocking agent for the arrhythmia. On discharge, he is advised to continue the medication for at least 2 years. Which of the following β-adrenergic blocking agents was most likely prescribed to this patient?
Q408
A 73-year-old woman recently diagnosed with colonic adenocarcinoma comes to the physician because of a 1-week history of nausea and multiple episodes of vomiting. These symptoms started shortly after her first infusion of oxaliplatin and fluorouracil. The patient is started on an appropriate medication. Three weeks later, at a follow-up appointment, she states that she has developed headaches and constipation. The patient was most likely treated with a drug with which of the following mechanisms of action?
Q409
Two hours after undergoing elective cholecystectomy with general anesthesia, a 41-year-old woman is evaluated for decreased mental status. BMI is 36.6 kg/m2. Respirations are 18/min and blood pressure is 126/73 mm Hg. Physical examination shows the endotracheal tube in normal position. She does not respond to sternal rub and gag reflex is absent. Arterial blood gas analysis on room air shows normal PO2 and PCO2 levels. Which of the following anesthetic properties is the most likely cause of these findings?
Q410
A 56-year-old man with type 2 diabetes mellitus comes to the physician for a follow-up examination. Three months ago, the patient was started on metformin therapy after counseling on diet, exercise, and weight reduction failed to reduce his hyperglycemia. Physical examination shows no abnormalities. His hemoglobin A1c is 8.4%. Pioglitazone is added to the patient's medication regimen. Which of the following cellular changes is most likely to occur in response to this new drug?
Autonomic/CV Drugs US Medical PG Practice Questions and MCQs
Question 401: A 70-year-old male immigrant from Asia is brought to the emergency room with complaints of palpitations and light-headedness for 1 hour. The patient was sitting in his chair watching television when he felt his heart racing and became dizzy. He was unable to stand up from his chair because of weakness and light-headedness. His past medical history is notable for mitral stenosis secondary to rheumatic fever as a child. On arrival to the emergency department, the patient's temperature is 99.7°F (37.6°C), blood pressure is 110/55 mmHg, pulse is 140/min, and respirations are 15/min. The patient appears comfortable but anxious. Electrocardiogram shows atrial fibrillation with rapid ventricular response. The patient is started on dofetilide. Which of the following would be expected in this patient’s cardiac action potential as a result of this drug?
A. Decreased conduction velocity
B. Increased QT interval (Correct Answer)
C. Decreased calcium current
D. Decreased slope of phase 0
E. Decreased slope of phase 4
Explanation: ***Increased QT interval***
- **Dofetilide** is a **Class III antiarrhythmic** drug that primarily blocks the delayed rectifier **potassium channels (Ik)** in cardiomyocytes.
- Blocking potassium efflux prolongs repolarization, which is reflected as a **prolonged action potential duration (APD)** and a lengthened **QT interval** on the electrocardiogram.
*Decreased conduction velocity*
- This effect is primarily associated with **Class I antiarrhythmic drugs** (e.g., flecainide, procainamide) which block **sodium channels**, thereby slowing the depolarization (Phase 0) and subsequent conduction velocity.
- **Dofetilide**, a Class III agent, does not directly impact sodium channels or significantly decrease conduction velocity.
*Decreased calcium current*
- A decreased calcium current (Phase 2) is characteristic of **Class IV antiarrhythmic drugs** (**calcium channel blockers** like verapamil and diltiazem).
- These drugs primarily act on nodal tissue to slow AV nodal conduction and heart rate, which is not the primary mechanism of action for **dofetilide**.
*Decreased slope of phase 0*
- The slope of **Phase 0 (depolarization)** is determined by the rapid influx of **sodium ions** into the cell.
- A decreased slope of Phase 0 would be expected with **Class I antiarrhythmic drugs** (sodium channel blockers), not with **dofetilide**, which targets potassium channels.
*Decreased slope of phase 4*
- The slope of **Phase 4 (spontaneous depolarization)** in pacemaker cells is primarily influenced by the "funny current" (If) and calcium currents.
- A decreased slope of Phase 4 is characteristic of **beta-blockers** (Class II antiarrhythmics) or **calcium channel blockers** that reduce the rate of spontaneous depolarization in nodal cells, thereby lowering heart rate. **Dofetilide** does not have this primary effect.
Question 402: A 57-year-old man calls his primary care physician to discuss the results of his annual laboratory exams. The results show that he has dramatically decreased levels of high-density lipoprotein (HDL) and mildly increased levels of low-density lipoprotein (LDL). The physician says that the HDL levels are of primary concern so he is started on the lipid level modifying drug that most effectively increases serum HDL levels. Which of the following is the most likely a side effect of this medication that the patient should be informed about?
A. Hepatotoxicity
B. Gallstones
C. Flushing (Correct Answer)
D. Malabsorption
E. Myalgia
Explanation: ***Flushing***
- The medication that most effectively increases HDL levels is **niacin (vitamin B3)**.
- A common and well-known side effect of niacin, especially at therapeutic doses, is **cutaneous flushing**, often accompanied by itching and warmth, due to prostaglandin release.
*Hepatotoxicity*
- While some lipid-modifying drugs, particularly statins, can cause hepatotoxicity, it is less characteristic of niacin directly affecting the liver.
- **Niacin** can cause mild liver enzyme elevations but severe hepatotoxicity is rare with standard doses and monitoring.
*Gallstones*
- **Fibrates** (e.g., gemfibrozil, fenofibrate) are known to increase the risk of gallstone formation by increasing cholesterol excretion into bile.
- Fibrates primarily lower triglycerides and can moderately increase HDL, but are not the *most effective* for significantly raising HDL.
*Malabsorption*
- **Bile acid sequestrants** (e.g., cholestyramine, colestipol) can cause malabsorption of fat-soluble vitamins and other drugs.
- These drugs primarily lower LDL and have minimal effects on HDL levels.
*Myalgia*
- **Statins** (HMG-CoA reductase inhibitors) are well-known to cause muscle-related side effects, including myalgia, myopathy, and in severe cases, rhabdomyolysis.
- Statins primarily lower LDL, and their effect on HDL is generally modest.
Question 403: A 53-year-old male presents to his primary care provider for tremor of his right hand. The patient reports that the shaking started a few months ago in his right hand but that he worries about developing it in his left hand as well. He reports that the shaking is worse when he is sitting still or watching television and improves as he goes about his daily activities. The patient has a past medical history of hypertension, hyperlipidemia, and diabetes mellitus, and his home medications are hydrochlorothiazide, lisinopril, and atorvastatin. He works as an accountant and drinks 1-2 beers per week. He has a 15-pack-year smoking history but quit ten years ago. On physical exam, the patient has bilateral hand tremors with a frequency of 4-5 Hz. The tremor improves on finger-to-nose testing. His upper extremities also display a mild resistance to passive movement, and he has 2+ reflexes throughout. He has no gait abnormalities, and he scores 29/30 on the Mini-Mental State Examination (MMSE).
This patient should be started on which of the following classes of medications?
A. Acetylcholinesterase inhibitor
B. Sodium channel antagonist
C. Anticholinergic (Correct Answer)
D. Beta-blocker
E. GABA receptor modulator
Explanation: ***Anticholinergic***
- The patient exhibits classic signs of **Parkinson's disease**, including a **resting tremor** (improves with activity, worse at rest), **bradykinesia** (mild resistance to passive movement), and a tremor frequency of **4-5 Hz**.
- **Note on current practice**: While **dopaminergic agents (levodopa/carbidopa or dopamine agonists)** are the **preferred first-line treatment** for Parkinson's disease, they are not among the options listed. Among the available choices, **anticholinergics** like **benztropine** or **trihexyphenidyl** can be used for **tremor-predominant Parkinson's disease**, particularly in **younger patients** where tremor control is the primary goal.
- **Anticholinergics** block muscarinic acetylcholine receptors, reducing the cholinergic overdrive associated with dopamine deficiency. However, they are now **used less frequently** due to adverse effects (cognitive impairment, dry mouth, urinary retention, constipation), especially in older adults.
*Acetylcholinesterase inhibitor*
- **Acetylcholinesterase inhibitors** (e.g., donepezil, rivastigmine) are used to treat **Alzheimer's disease** and other dementias by increasing acetylcholine levels.
- They are **not indicated for Parkinson's disease tremor** and would likely **worsen motor symptoms** by further increasing cholinergic activity, which is already relatively excessive due to dopamine deficiency.
*Sodium channel antagonist*
- **Sodium channel antagonists** such as **carbamazepine** or **lamotrigine** are typically used as **antiepileptics** or for **mood stabilization** and neuropathic pain.
- They are **not indicated for Parkinsonian tremor** and do not address the underlying dopaminergic deficiency in Parkinson's disease.
*Beta-blocker*
- **Beta-blockers** such as **propranolol** are the **first-line treatment for essential tremor**, which presents as an **action/postural tremor** that worsens with movement and goal-directed activity.
- This patient's tremor is a **resting tremor** that **improves with activity**, which is characteristic of **Parkinson's disease, not essential tremor**. Beta-blockers would not be effective for resting tremor.
*GABA receptor modulator*
- **GABA receptor modulators** such as **benzodiazepines** (e.g., clonazepam) or **barbiturates** may be used for **essential tremor** as second-line agents or for **anxiety-induced tremor**.
- They are **not a primary treatment for Parkinson's disease tremor** and do not address the underlying dopaminergic pathophysiology. Additionally, they carry risks of sedation, dependence, and cognitive impairment.
Question 404: A 52-year-old man with a history of hypertension and hyperlipidemia comes to the physician because of a 10-month history of substernal chest pain on exertion that is relieved with rest. His pulse is 82/min and blood pressure is 145/82 mm Hg. He is prescribed a drug that acts by forming free radical nitric oxide. The patient is most likely to experience which of the following adverse effects as a result of this drug?
A. Pulsating headaches (Correct Answer)
B. Erectile dysfunction
C. Hypertensive urgency
D. Lower extremity edema
E. Nonproductive cough
Explanation: ***Pulsating headaches***
- The drug described is likely **nitroglycerin** or another **nitrate**, which acts by releasing **nitric oxide (NO)** to cause **vasodilation**.
- **Vasodilation** in the cerebral vasculature is a common side effect of nitrates and can lead to **pulsating headaches**.
*Erectile dysfunction*
- **Erectile dysfunction** is not a direct adverse effect of nitrates; in fact, nitrates can be used to treat it, though their use with PDE5 inhibitors is contraindicated.
- This condition is more commonly associated with the underlying cardiovascular disease rather than the medication used to treat angina.
*Hypertensive urgency*
- **Nitrates** cause **vasodilation** and typically **lower blood pressure**, making **hypotension** (not hypertension) a potential side effect.
- **Hypertensive urgency** would indicate a sudden, severe elevation in blood pressure, which is antithetical to the drug's mechanism of action.
*Lower extremity edema*
- **Lower extremity edema** is generally not a direct side effect of nitrates; it is more commonly associated with conditions like **heart failure**, certain **calcium channel blockers**, or **venous insufficiency**.
- While vasodilation can sometimes lead to fluid shifts, edema is not a prominent or expected adverse effect of this class of drugs.
*Nonproductive cough*
- A **nonproductive cough** is a common side effect of **ACE inhibitors** (e.g., lisinopril), which act on the **renin-angiotensin-aldosterone system**.
- This symptom is not associated with **nitrates** because their mechanism of action is primarily through nitric oxide-mediated vasodilation, unrelated to the respiratory irritation seen with ACE inhibitors.
Question 405: A 68-year-old male with a history of congestive heart failure presents to his cardiologist complaining of mild dyspnea on exertion and swollen ankles. His past medical history is also significant for hypertension and alcohol abuse. He has a 50 pack-year smoking history. He currently takes lisinopril, aspirin, and metoprolol. His temperature is 99°F (37.2°C), blood pressure is 135/85 mmHg, pulse is 85/min, and respirations are 18/min. An echocardiogram reveals an ejection fraction of 35%. His cardiologist adds an additional medication to the patient’s regimen. Two weeks later, the patient notices yellow halos in his vision. Which of the following medications did this patient most likely start taking?
A. Dobutamine
B. Nitroprusside
C. Hydralazine
D. Digoxin (Correct Answer)
E. Furosemide
Explanation: ***Digoxin***
- The patient's symptoms (dyspnea on exertion, swollen ankles, reduced ejection fraction) indicate **heart failure**. **Digoxin** is a cardiac glycoside used to improve cardiac output in heart failure.
- **Yellow halos in vision** are a classic symptom of **digoxin toxicity**, which can occur if drug levels become too high.
*Dobutamine*
- **Dobutamine** is a **beta-1 adrenergic agonist** used as an inotrope in acute decompensated heart failure to improve cardiac contractility.
- It is typically administered intravenously for short-term management and is not associated with yellow halos in vision.
*Nitroprusside*
- **Nitroprusside** is a potent **vasodilator** used for hypertensive emergencies and in some cases of acute decompensated heart failure to reduce preload and afterload.
- It is also administered intravenously and is not associated with the visual disturbances described.
*Hydralazine*
- **Hydralazine** is a direct **arterial vasodilator** used to reduce afterload in heart failure, often in combination with nitrates. It can cause reflex tachycardia.
- While used in chronic heart failure, it does not typically cause visual changes such as yellow halos.
*Furosemide*
- **Furosemide** is a **loop diuretic** used to reduce fluid overload in heart failure, alleviating symptoms like edema and dyspnea.
- While it can cause ototoxicity at high doses or in renal impairment, it does not cause yellow halos in vision.
Question 406: A previously healthy 36-year-old woman comes to the emergency department because of a progressively worsening headache for 5 days. She vomited twice after waking up this morning. She does not smoke or drink alcohol. She is sexually active with one male partner and uses an oral contraceptive. Her temperature is 37.5°C (99.5°F), pulse is 105/min, and blood pressure is 125/80 mm Hg. Examination shows tearing of the right eye. The pupils are equal and reactive to light; right lateral gaze is limited. Fundoscopic examination shows bilateral optic disc swelling. The remainder of the examination shows no abnormalities. An MR venography of the head shows a heterogeneous intensity in the left lateral sinus. Which of the following is the most appropriate next step in management?
A. Administer dalteparin (Correct Answer)
B. Analyze cerebrospinal fluid
C. Administer intravenous antibiotics
D. Perform endovascular thrombolysis
E. Measure D-dimer levels
Explanation: **Administer dalteparin**
- The patient presents with classic signs and symptoms of **cerebral venous sinus thrombosis (CVST)**: worsening headache, vomiting, papilledema (optic disc swelling), and a risk factor (oral contraceptive use). The MR venography confirms a heterogeneous intensity in the left lateral sinus, consistent with a thrombus. **Anticoagulation with unfractionated or low molecular weight heparin (such as dalteparin)** is the first-line treatment to prevent clot propagation and recanalize the occluded sinus.
- **Dalteparin** is a **low molecular weight heparin (LMWH)**, which is preferred over unfractionated heparin in many situations due to its predictable anticoagulant response and lower risk of heparin-induced thrombocytopenia. Prompt anticoagulation is crucial in preventing further neurological deficits and reducing morbidity.
*Analyze cerebrospinal fluid*
- While a **lumbar puncture** might show elevated opening pressure in CVST, it is **contraindicated prior to imaging** to exclude mass effect or obtundation, and in this case, imaging has already confirmed a thrombus.
- CSF analysis is generally not the initial diagnostic or management priority in suspected CVST, especially when imaging has identified the thrombus.
*Administer intravenous antibiotics*
- The patient's symptoms are not suggestive of an **infectious etiology** like meningitis or encephalitis; despite a low-grade fever, there are no other clear signs of infection.
- Administering antibiotics without a strong indication for infection would be inappropriate and delay the necessary treatment for the confirmed **thrombosis**.
*Perform endovascular thrombolysis*
- **Endovascular thrombolysis** is a more invasive procedure generally reserved for patients who **fail to improve with anticoagulation** or have severe neurological deficits that are rapidly progressing despite adequate medical management.
- It carries higher risks compared to systemic anticoagulation and is not the first-line treatment for CVST.
*Measure D-dimer levels*
- While **elevated D-dimer levels** can indicate an active thrombotic process, they are **non-specific** and can be elevated in various conditions.
- D-dimer testing would not provide additional diagnostic information beyond what the MR venography has already confirmed and would not guide immediate management.
Question 407: A 48-year-old man presents to the emergency department with complaints of substernal chest pain for the past 1 hour. The pain is crushing in nature and radiates to his neck and left arm. He rates the pain as 7/10. He gives a history of similar episodes in the past that resolved with rest. He is a non-smoker and drinks alcohol occasionally. On physical examination, the temperature is 37.0°C (98.6°F), the pulse rate is 130/min and irregular, the blood pressure is 148/92 mm Hg, and the respiratory rate is 18/min. The physician immediately orders an electrocardiogram, the findings of which are consistent with an acute Q-wave myocardial infarction (MI). After appropriate emergency management, he is admitted to the medical floor. He develops atrial fibrillation on the second day of admission. He is given a β-adrenergic blocking agent for the arrhythmia. On discharge, he is advised to continue the medication for at least 2 years. Which of the following β-adrenergic blocking agents was most likely prescribed to this patient?
A. Atenolol (Correct Answer)
B. Penbutolol
C. Acebutolol
D. Pindolol
E. Celiprolol
Explanation: ***Atenolol***
- **Atenolol** is a **cardioselective β1-blocker** that is commonly prescribed for atrial fibrillation, especially post-MI, due to its efficacy in reducing heart rate and improving survival.
- It lacks **intrinsic sympathomimetic activity (ISA)**, which is crucial for the post-MI setting to ensure adequate beta-blockade and prevent adverse cardiac events.
*Penbutolol*
- **Penbutolol** is a **non-selective β-blocker** with **intrinsic sympathomimetic activity (ISA)**.
- Beta-blockers with ISA are generally **contraindicated or not preferred** in post-MI patients because their partial agonist activity might negate the protective effects of beta-blockade on myocardial oxygen demand and arrhythmogenesis.
*Acebutolol*
- **Acebutolol** is a **cardioselective β1-blocker** with **intrinsic sympathomimetic activity (ISA)**.
- Like other beta-blockers with ISA, acebutolol is **not typically recommended** for long-term use after myocardial infarction due to concerns about reduced cardioprotective benefits.
*Pindolol*
- **Pindolol** is a **non-selective β-blocker** with **intrinsic sympathomimetic activity (ISA)**.
- Its partial agonist activity can lead to **less reduction in heart rate and myocardial contractility** compared to beta-blockers without ISA, making it an unsuitable choice for post-MI management.
*Celiprolol*
- **Celiprolol** is a **cardioselective β1-blocker** that also has **β2-agonist properties** and **intrinsic sympathomimetic activity (ISA)**.
- Its β2-agonist and ISA effects make it **less desirable post-MI** as it may not provide the full cardioprotective benefits of a pure β-blocker.
Question 408: A 73-year-old woman recently diagnosed with colonic adenocarcinoma comes to the physician because of a 1-week history of nausea and multiple episodes of vomiting. These symptoms started shortly after her first infusion of oxaliplatin and fluorouracil. The patient is started on an appropriate medication. Three weeks later, at a follow-up appointment, she states that she has developed headaches and constipation. The patient was most likely treated with a drug with which of the following mechanisms of action?
A. 5-HT3 receptor antagonist (Correct Answer)
B. H1 receptor antagonist
C. NK1 receptor antagonist
D. Cannabinoid receptor agonist
E. M2 receptor antagonist
Explanation: ***5-HT3 receptor antagonist***
- The patient's symptoms of nausea and vomiting after **oxaliplatin and fluorouracil** chemotherapy are consistent with **chemotherapy-induced nausea and vomiting (CINV)**.
- **5-HT3 receptor antagonists** (e.g., ondansetron) are the primary treatment for CINV, and their common side effects include **headache and constipation**.
*H1 receptor antagonist*
- **H1 receptor antagonists** (e.g., diphenhydramine) can be used as antiemetics, but they are generally less effective for severe CINV and are associated with side effects such as **sedation and anticholinergic effects** (e.g., dry mouth), not typically headache and constipation as the primary concern.
- They work by blocking histamine-1 receptors in the **vomiting center**, but their efficacy in CINV is limited compared to 5-HT3 antagonists.
*NK1 receptor antagonist*
- **NK1 receptor antagonists** (e.g., aprepitant) are often used in combination with 5-HT3 antagonists and corticosteroids for highly emetogenic chemotherapy.
- While effective, their common side effect profile does not typically highlight **headache and constipation** as prominently as 5-HT3 antagonists do, and they are usually not chosen as a monotherapy first-line for moderate CINV.
*Cannabinoid receptor agonist*
- **Cannabinoid receptor agonists** (e.g., dronabinol) are used for CINV, especially in patients who do not respond to other antiemetics, and also to stimulate appetite.
- Their common side effects include **dizziness, euphoria, dysphoria**, and **hypotension**, but not typically headache and constipation as the most prominent adverse effects.
*M2 receptor antagonist*
- **M2 receptor antagonists** target muscarinic acetylcholine receptors, and while some anticholinergics might have antiemetic properties, using an M2-specific antagonist as a primary antiemetic for CINV is not standard practice.
- There are no commonly used antiemetics for CINV that specifically act as **M2 receptor antagonists**, and this class of drugs is more relevant in contexts such as heart rate regulation.
Question 409: Two hours after undergoing elective cholecystectomy with general anesthesia, a 41-year-old woman is evaluated for decreased mental status. BMI is 36.6 kg/m2. Respirations are 18/min and blood pressure is 126/73 mm Hg. Physical examination shows the endotracheal tube in normal position. She does not respond to sternal rub and gag reflex is absent. Arterial blood gas analysis on room air shows normal PO2 and PCO2 levels. Which of the following anesthetic properties is the most likely cause of these findings?
A. Low blood solubility
B. High lipid solubility (Correct Answer)
C. Low brain-blood partition coefficient
D. High minimal alveolar concentration
E. Low cytochrome P450 activity
Explanation: ***High lipid solubility***
- Anesthetics with **high lipid solubility** accumulate in **adipose tissue** and are slowly released, prolonging their effect, especially in obese patients.
- The patient's **obesity (BMI 36.6 kg/m2)** contributes to a larger reservoir for lipid-soluble drugs, leading to delayed recovery and decreased mental status.
*Low blood solubility*
- **Low blood solubility** implies a rapid equilibrium between the lungs and the blood, leading to a **faster onset and offset** of anesthetic action.
- This property would result in a quicker recovery from anesthesia, which contradicts the patient's prolonged unconsciousness.
*Low brain-blood partition coefficient*
- A **low brain-blood partition coefficient** means the anesthetic does not accumulate significantly in brain tissue relative to blood.
- Agents with this property equilibrate quickly and leave the brain rapidly upon discontinuation, resulting in **fast recovery**, which is inconsistent with the patient's persistent decreased mental status.
*High minimal alveolar concentration*
- **High minimal alveolar concentration (MAC)** means that a higher concentration of the anesthetic gas is required to produce immobility in 50% of patients.
- A high MAC describes the **potency** of an anesthetic and does not directly explain prolonged recovery or decreased mental status in an obese patient, but rather indicates that a larger dose or concentration was needed to achieve anesthesia.
*Low cytochrome P450 activity*
- **Low cytochrome P450 activity** would lead to slower metabolism of drugs that are primarily cleared by this system, potentially prolonging their effects.
- While relevant for some drugs, the primary issue for inhaled anesthetics is their **physical distribution and elimination**, not typically metabolic clearance via Cytochrome P450 enzymes.
Question 410: A 56-year-old man with type 2 diabetes mellitus comes to the physician for a follow-up examination. Three months ago, the patient was started on metformin therapy after counseling on diet, exercise, and weight reduction failed to reduce his hyperglycemia. Physical examination shows no abnormalities. His hemoglobin A1c is 8.4%. Pioglitazone is added to the patient's medication regimen. Which of the following cellular changes is most likely to occur in response to this new drug?
A. Depolarization of pancreatic β-cells
B. Decreased sodium-dependent glucose cotransport
C. Decreased breakdown of glucagon-like peptide 1
D. Increased transcription of adipokines (Correct Answer)
E. Autophosphorylation of receptor tyrosine kinase
Explanation: ***Increased transcription of adipokines***
- **Pioglitazone** is a **thiazolidinedione (TZD)** that acts as an **agonist for peroxisome proliferator-activated receptor-gamma (PPAR-γ)**.
- Activation of PPAR-γ in adipocytes leads to increased transcription of genes involved in **glucose uptake and lipid metabolism**, including certain **adipokines** that improve insulin sensitivity.
*Depolarization of pancreatic β-cells*
- This is the mechanism of **sulfonylureas** (e.g., glipizide, glyburide) or **meglitinides** (e.g., repaglinide, nateglinide), which stimulate insulin release by closing K+ channels and depolarizing β-cells.
- Pioglitazone does not directly stimulate insulin secretion from β-cells.
*Decreased sodium-dependent glucose cotransport*
- This is the mechanism of **SGLT2 inhibitors** (e.g., empagliflozin, canagliflozin, dapagliflozin), which reduce glucose reabsorption in the renal tubules.
- Pioglitazone primarily acts by sensitizing peripheral tissues to insulin.
*Decreased breakdown of glucagon-like peptide 1*
- This is the mechanism of **DPP-4 inhibitors** (e.g., sitagliptin, saxagliptin), which prevent the degradation of GLP-1, thereby increasing its levels and effect.
- Pioglitazone does not directly affect GLP-1 metabolism.
*Autophosphorylation of receptor tyrosine kinase*
- This is the initial step in the **insulin signaling pathway** when insulin binds to its receptor.
- While pioglitazone improves insulin sensitivity, it does not directly cause autophosphorylation of the insulin receptor itself; rather, it upregulates pathways downstream or parallel to it that enhance insulin's effects.